You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoglobulin

Showing 26 - 50 of 4,146
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PANS Pediatric Acute-Onset Neuropsychiatric Syndrome Trial in Gothenburg (Privigen Injectable Product (Intravenous

Recruiting
  • PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
  • Privigen Injectable Product (Intravenous Immunoglobulin)
  • Gothenburg, Sweden
    Gillberg Neuropsychiatry Centre
Aug 13, 2022

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

MRD Detection by NGS in Pediatric B-ALL

Completed
  • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
  • MRD
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023

Subcutaneous Immunoglobulin in Primary and Secondary

Not yet recruiting
  • Primary Immune Deficiency Disorder
  • Secondary Immune Deficiency
  • Edmonton, Alberta, Canada
    University of Alberta
Jun 14, 2022

IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

Recruiting
  • IgG4 Related Disease
  • IgG4-RD
  • Atlanta, Georgia
  • +2 more
Jul 13, 2022

Outcomes Study (FIGARO)

Completed
  • Primary Immunodeficiency
  • Secondary Immune Deficiency
  • HyQvia
  • Paris, France
  • +3 more
Mar 18, 2022

Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)

Recruiting
  • Immunoglobulin A Nephropathy
  • +5 more
  • Leicester, United Kingdom
    Leicester General Hospital, University Hospitals of Leicester NH
May 18, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Recruiting
  • Allergy and Immunology
  • collection of blood and urine
  • Toulouse, France
  • +1 more
May 17, 2022

Female Reproductive Cancer Trial in Rochester (serum-derived bovine immunoglobulin protein isolate, , laboratory biomarker

Active, not recruiting
Has Results
  • Female Reproductive Cancer
  • serum-derived bovine immunoglobulin protein isolate
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Feb 3, 2022

Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)

Recruiting
  • Advanced Malignant Tumors
  • doxorubicin hydrochloride liposome injection
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 28, 2022

Kawasaki Disease Trial in Le Kremlin-Bicêtre (ANAKINRA, Intravenous immunoglobulin)

Not yet recruiting
  • Kawasaki Disease
  • Le Kremlin-Bicêtre, Val De Marne, France
    CHU de Bicêtre
Jun 17, 2022

Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg, Placebo)

Recruiting
  • Immunoglobulin A Nephropathy
  • Sibeprenlimab 400 mg
  • Placebo
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Mar 25, 2022

Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

Not yet recruiting
  • Immunoglobulin Light-chain Amyloidosis
  • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • (no location specified)
Mar 18, 2023

Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)

Not yet recruiting
  • BK Viremia
  • +2 more
  • Immunosuppression reduction/modification + intravenous immunoglobulin
  • Immunosuppression reduction/modification
  • (no location specified)
Oct 16, 2022

Haploidentical Stem Cell Transplantation, Conditioning Trial in Xi'an (MA-BUCY2, BUCY2)

Not yet recruiting
  • Haploidentical Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))

Completed
  • Tetanus
  • TNM002 (low dose)
  • +4 more
  • Shantou, Guangdong, China
  • +3 more
Nov 20, 2022

Down Syndrome, Regression Trial (Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib)

Not yet recruiting
  • Down Syndrome
  • Regression
  • (no location specified)
Dec 14, 2022

HFRS (Hemorrhagic Fever With Renal Syndrome) Trial in China (IVIG 20g/d, IVIG 10g/d)

Recruiting
  • HFRS (Hemorrhagic Fever With Renal Syndrome)
  • IVIG 20g/d
  • IVIG 10g/d
  • Guangshui, Hu Bei Province, China
  • +8 more
Aug 22, 2023

Bronchiectasis, Immunoglobulin Subclass Deficiency Trial in Edinburgh (Cuvitru 20 % Injectable Solution)

Withdrawn
  • Bronchiectasis
  • Immunoglobulin Subclass Deficiency
  • Cuvitru 20 % Injectable Solution
  • Edinburgh, United Kingdom
    Royal Infirmary of Edinburgh
Sep 28, 2021

Immunoglobulin A Nephropathy Trial in New York (Sibeprenlimab 400 mg s.c. Q4weeks)

Not yet recruiting
  • Immunoglobulin A Nephropathy
  • Sibeprenlimab 400 mg s.c. Q4weeks
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Feb 18, 2022

Intravenous Immunoglobulin Treatment in Chronic Inflammatory

Completed
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    • Paris, France
      Groupe Hospitalier Paris Saint-Joseph
    Mar 30, 2022

    Rabies Post-exposure Prophylaxis Trial in Kunming (GR1801, Human Rabies Immunoglobulin(HRIG), Rabies Vaccine)

    Recruiting
    • Rabies Post-exposure Prophylaxis
    • GR1801
    • +2 more
    • Kunming, Yunnan, China
      Center for Disease Control and Prevention (CDC)
    May 3, 2023

    Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

    Not yet recruiting
    • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Dec 8, 2022

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023